My DyslipidemiaXpert

[space]	Find documents with all the words specified. dopamine homeostasis will get documents with dopamine and homeostasis, found documents must contain the two elements.
OR	Find documents with at least one of the words specified. dopamine OR homeostasis will get documents with word dopamine or homeostasis.
-	The sign - exclude the documents with word or expression specified. dopamine - homeostasis will get the documents with dopamine but without homeostasis. The sign - must be used with others operators.
" "	Find the documents with exactly the expression between the two quotation marks. Example: "symptomatic medication" will find only the documents with "symptomatic medication" in the document.
( )	Brackets are used to group words in a sub expression: (dopamine homeostasis) OR (ergotamine headache)
*	Asterisk is the truncation operator. It can be used as a prefix (with quotation marks) or suffix. *dopa homeo, dopne or "cature"*.

What's new in DyslipidemiaLast update of the site: Tuesday March 19, 2019

Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and...

I. Dicembrini et al. | Journal of Endocrinological Investigation...

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are monoclonal antibodies, recently...

Read article

Modifiable Clinical Correlates of Vascular Health in Children and Adolescents...

David A et al. | Pediatric Cardiology 2019; aop: 10.1007/s00246-019-02071-w...

Atherosclerosis promoting cardiovascular disease risk factors (CVDrf) are highly prevalent among children...

Read article

High‐density lipoprotein lipid peroxidation as a molecular signature of...

Sara Samadi et al. | Journal of Cellular Physiology 2019;...

Cardiovascular disease (CVD) is a major cause of morbidity and mortality, globally. The prevalence of...

Read article

Disentangling the Effects of Monounsaturated Fatty Acids from Other Components...

Charlotte C. J. R. Michielsen et al. | Molecular Nutrition & Food Research...

Cardiovascular diseases (CVDs) are the main cause of death worldwide.1 The development of CVD and...

Read article

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With...

Christie M et al. | Cardiology and therapy 2019; aop: 10.1007/s40119-019-0131-8...

Fatty acids are an important energy substrate, but specific fatty acids also play consequential and distinct...

Read article

Metabolic effect of berberine–silymarin association: A meta‐analysis...

Federica Fogacci et al. | Phytotherapy Research 2019; AOP: 10.1002/ptr.6282...

Berberine (BBR) is a quaternary benzylisoquinoline alkaloid present in the root, rhizome, stem, fruit,...

Read article

New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic...

R. Preston Mason et al. | Current atherosclerosis reports 2019;...

While statins have significantly reduced the global burden of atherosclerotic cardiovascular disease...

Read article

Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke...

Shen, Yun Md et al. | Stroke 2019; 50(2): 291-7

Low level of HDL (high-density lipoprotein) cholesterol is a well-established risk factor for cardiovascular...

Read article

Clinical Management of High and Very High Risk Patients with Hyperlipidaemia...

Ivo Petrov et al. | Advances in Therapy 2019; 36(3): 608-20...

Hyperlipidaemia is a major modifiable risk factor for the development of cardiovascular (CV) disease,...

Read article

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct...

Mathijs C et al. | Cardiology and therapy 2019; aop: 10.1007/s40119-019-0126-5...

In patients with ST-segment elevation myocardial infarction (STEMI), primary percutaneously coronary...

Read article

Read more
More scientific & medical news in your area of expertise

Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study

Yokoyama Katsuaki et al. | BMC Cardiovascular Disorders 2018; 18(1):... Read article

Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

Sicras-Mainar A. et al. | Lipids in Health and Disease 2018; 17(1):... Read article

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study

Gourgari Evgenia et al. | Cardiovascular Diabetology 2018; 17(1):... Read article

The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial

Samkani Amirsalar et al. | Lipids in Health and Disease 2018; 17(1):... Read article

Changes in Lipid Indices in HIV+ Cases on HAART

Ji Shujing et al. | BioMed Research International 2019 (2019),... Read article

01 - Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials

I. Dicembrini et al. | Journal of Endocrinological Investigation...

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are monoclonal antibodies, recently introduced in the treatment of hypercholesterolemia for patients who do not achieve therapeutic targets...

Read article

02 - Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials

Federica Fogacci et al. | Phytotherapy Research 2019; AOP: 10.1002/ptr.6282...

Berberine (BBR) is a quaternary benzylisoquinoline alkaloid present in the root, rhizome, stem, fruit, and bark of different species of plants as Coptis (Callosobruchus chinensis, japonica),...

Read article

03 - New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease

R. Preston Mason et al. | Current atherosclerosis reports 2019;...

While statins have significantly reduced the global burden of atherosclerotic cardiovascular disease (ASCVD), there is still residual risk for clinical events among patients, such as those with type 2...

Read article

04 - Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study

Ivo Petrov et al. | Advances in Therapy 2019; 36(3): 608-20...

Hyperlipidaemia is a major modifiable risk factor for the development of cardiovascular (CV) disease, the leading cause of death and disability in the developed world [1]. It is estimated that up to 50%...

Read article

05 - Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus

Shen, Yun Md et al. | Stroke 2019; 50(2): 291-7

Low level of HDL (high-density lipoprotein) cholesterol is a well-established risk factor for cardiovascular diseases (CVD).1 A recent meta-analysis of individual data from 61 prospective studies found...

Read article

What's new in DyslipidemiaLast update of the site: Tuesday March 19, 2019

Bibliographical searchFocus and target to your research of scientific data

Top articlesThe 5 most read articles

01 - Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials

02 - Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials

03 - New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease

04 - Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study

05 - Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus

Usefuls linksWhat else?